Kusunoki H - Search Results

1

Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B.

Congrains A, Kamide K, Oguro R, Yasuda O, Miyata K, Yamamoto E, Kawai T, Kusunoki H, Yamamoto H, Takeya Y, Yamamoto K, Onishi M, Sugimoto K, Katsuya T, Awata N, Ikebe K, Gondo Y, Oike Y, Ohishi M, Rakugi H. Congrains A, et al. Among authors: kusunoki h. Atherosclerosis. 2012 Feb;220(2):449-55. doi: 10.1016/j.atherosclerosis.2011.11.017. Epub 2011 Nov 19. Atherosclerosis. 2012. PMID: 22178423

2

Hepatocyte growth factor attenuates renal fibrosis through TGF-β1 suppression by apoptosis of myofibroblasts.

Iekushi K, Taniyama Y, Azuma J, Sanada F, Kusunoki H, Yokoi T, Koibuchi N, Okayama K, Rakugi H, Morishita R. Iekushi K, et al. Among authors: kusunoki h. J Hypertens. 2010 Dec;28(12):2454-61. doi: 10.1097/HJH.0b013e32833e4149. J Hypertens. 2010. PMID: 20842048

3

Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway.

Iekushi K, Taniyama Y, Kusunoki H, Azuma J, Sanada F, Okayama K, Koibuchi N, Iwabayashi M, Rakugi H, Morishita R. Iekushi K, et al. Among authors: kusunoki h. Hypertension. 2011 Aug;58(2):190-6. doi: 10.1161/HYPERTENSIONAHA.111.173013. Epub 2011 Jun 13. Hypertension. 2011. PMID: 21670418

4

Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.

Iwabayashi M, Taniyama Y, Sanada F, Azuma J, Iekushi K, Kusunoki H, Chatterjee A, Okayama K, Rakugi H, Morishita R. Iwabayashi M, et al. Among authors: kusunoki h. Atherosclerosis. 2012 Feb;220(2):337-42. doi: 10.1016/j.atherosclerosis.2011.10.042. Epub 2011 Nov 9. Atherosclerosis. 2012. PMID: 22172591

5

Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.

Kusunoki H, Taniyama Y, Azuma J, Iekushi K, Sanada F, Otsu R, Iwabayashi M, Okayama K, Rakugi H, Morishita R. Kusunoki H, et al. Hypertension. 2012 Feb;59(2):308-16. doi: 10.1161/HYPERTENSIONAHA.111.176263. Epub 2012 Jan 17. Hypertension. 2012. PMID: 22252391

6

Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition.

Okayama K, Azuma J, Dosaka N, Iekushi K, Sanada F, Kusunoki H, Iwabayashi M, Rakugi H, Taniyama Y, Morishita R. Okayama K, et al. Among authors: kusunoki h. Hypertension. 2012 May;59(5):958-65. doi: 10.1161/HYPERTENSIONAHA.111.183905. Epub 2012 Mar 5. Hypertension. 2012. PMID: 22392903

7

Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension.

Kusunoki H, Taniyama Y, Rakugi H, Morishita R. Kusunoki H, et al. J Am Heart Assoc. 2013 Apr 22;2(2):e000103. doi: 10.1161/JAHA.113.000103. J Am Heart Assoc. 2013. PMID: 23608606 Free PMC article.

8

Anti-inflammatory effects of hepatocyte growth factor on the vicious cycle of macrophages and adipocytes.

Kusunoki H, Taniyama Y, Otsu R, Rakugi H, Morishita R. Kusunoki H, et al. Hypertens Res. 2014 Jun;37(6):500-6. doi: 10.1038/hr.2014.41. Epub 2014 Mar 13. Hypertens Res. 2014. PMID: 24621470

9

Improvement of metabolic syndrome by irbesartan via the PPARγ/HGF pathway in apolipoprotein E knockout mice.

Chatterjee A, Kusunoki H, Taniyama Y, Rakugi H, Morishita R. Chatterjee A, et al. Among authors: kusunoki h. Biomed Rep. 2013 Jan;1(1):65-70. doi: 10.3892/br.2012.28. Epub 2012 Oct 25. Biomed Rep. 2013. PMID: 24648895 Free PMC article.

10

Disease-associated polymorphisms in 9p21 are not associated with extreme longevity.

Congrains A, Kamide K, Hirose N, Arai Y, Oguro R, Nakama C, Imaizumi Y, Kawai T, Kusunoki H, Yamamoto H, Onishi-Takeya M, Takeya Y, Yamamoto K, Sugimoto K, Akasaka H, Saitoh S, Miura T, Awata N, Kato N, Katsuya T, Ikebe K, Gondo Y, Rakugi H. Congrains A, et al. Among authors: kusunoki h. Geriatr Gerontol Int. 2015 Jun;15(6):797-803. doi: 10.1111/ggi.12346. Epub 2014 Sep 26. Geriatr Gerontol Int. 2015. PMID: 25257646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters